Cisco Systems plans to build small cellular base stations, building upon its fast-growing business in Wi-Fi base stations for mobile operator networks, Chairman and CEO John Chambers said on Tuesday. The move will bring the networking ...
AT&T will invest $14 billion over the next three years for wireless and wired capital improvements, including an expansion of 4G LTE service to 300 million people by the end of 2014, the carrier announced today. Previously, AT&T said it ...
Tags: next three years, wireless networks, wired networks, 4G LTE service
The Wireless Broadband Alliance has announced that it is teaming up with the Small Cell Forum to deepen integration between Wi-Fi hotspots and licensed small cells. A number of companies already manufacture small cells that incorporate ...
Tags: Wireless Broadband Alliance, Small Cell Forum, WiFi hotspots, small cells
For second-quarter 2012, GaAs-based broadband wireless and wireline communications component maker Anadigics Inc of Warren, NJ, USA has reported net sales of $25.1m, down 11.7% on $28.4m last quarter and 29.5% on $35.6m a year ago. ...
Tags: Anadigics, financial report, USA, wireless and wireline communications
RF and microwave component distributor RFMW Ltd of San Jose, CA, USA has announced design and sales support for the TQP7M9106, a high-linearity driver amplifier with frequency coverage from 50MHz to 1.5GHz made by RF front-end product maker ...
Tags: RFMW, high-linearity amplifier, family
Samsung announced it will help develop Sprint's small-cell infrastructure for use in Sprint's 4G LTE network and its 3G network improvements. Samsung, also the top mobile phone provider in the U.S., said in a statement Thursday that the ...
Tags: Samsung, small cell, Sprint, 4G LTE network, 3G network
Despite widespread calls for more spectrum to carry mobile data, there is a wide range of technologies already being used or explored that could help to speed up networks or put off the day when more frequencies need to be cleared. ...
Tags: spectrum, mobile data, technologies, could, networks
Sprint plans to deploy small cell gear from Alcatel-Lucent to augment its wireless coverage -- including in its new 4G LTE network -- in high-traffic areas, the two companies announced Monday. Alcatel-Lucent's LightRadio Metro Cells are ...
Tags: Sprint, small cell gear, wireless coverage, LTE network
Sprint 4G engineering manager Viet chu shows off a new Alcatel Lucent router for LTE service in Baltimore. Sprint officials showed off new 4G LTE cellular service today in Baltimore, the carrier's 16th market in the U.S. to get the ...
Tags: Sprint officials, 4G LTE cellular service, Baltimore, U.S.
Virgin Media is in discussions with 30 cities across the UK about deploying free fibre-based Wi-Fi networks using small cell technology. Duncan Watts, head of business development for fixed and wireless at Virgin Media Business, revealed ...
Tags: Wi-Fi, Super Connected Cities, Virgin Media
Clarient Diagnostic Services, a GE Healthcare company, has entered into an agreement to license genomic biomarker for lung cancer from Insight Genetics. AS per the agreement, Clarient intends to develop and assess the performance ...
Tags: Lung Cancer, cooperation, medical technology
Astellas Pharma US is seeking FDA approval for Tarceva tablets to treat non-small cell lung cancer patients (NSCLC) with tumors containing epidermal growth factor receptor (EGFR) that triggers mutations. The company submitted a ...
Multinational biopharmaceutical company Celgene has received US Food and Drug Administration (FDA) approval for Abraxane, which is aimed to treat locally advanced or metastatic non-small cell lung cancer in combination with carboplatin in ...
Tags: Abraxane, lung cancer, Multinational biopharmaceutical company Celgene
Proacta, a San Diego based biotechnology company, has announced FDA approval of investigational new drug (IND) application for PR610, a hypoxia-activated irreversible multi-kinase inhibitor, for the treatment of cancer. With the IND ...
Tags: investigational new drug, IND
The European Commission has granted conditional marketing authorization for Pfizer’s Xalkori (crizotinib) to treat anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in the European Union (EU). ...
Tags: Xalkori, crizotinib, anaplastic lymphoma kinase, ALK